<!DOCTYPE html>
<html lang="en">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    <meta charset="utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <!-- Font Awesome -->
    <link
      rel="stylesheet"
      href="https://use.fontawesome.com/releases/v5.8.1/css/all.css"
      integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf"
      crossorigin="anonymous"
    />
    <!-- css -->
    <link href="styletest.css" rel="stylesheet" />
    <!-- fonts -->
    <link
      href="https://fonts.googleapis.com/css?family=Montserrat|Oswald"
      rel="stylesheet"
    />
    <!-- jquery -->
    <script src="https://code.jquery.com/jquery-1.10.2.js"></script>

    <title>Project Description</title>
  </head>
  <body>
    <!--
      ------------------------------------------------------TOP LOGO---------------------------------------------------------------
    -->
    <div class="header">
      <img
        src="logos/vibx/vibx_tp1.png"
        style="width: 100%; margin-top: 0%; background-position: center; left: 0; right: 0;"
      />
    </div>

    <!--
      ------------------------------------------------------SCROLL UP BUTTON---------------------------------------------------------------
    -->
    <button onclick="topFunction()" id="myBtn" title="Go to top">
      <i class="fas fa-arrow-circle-up"></i>
    </button>

    <script>
      // When the user scrolls down 20px from the top of the document, show the button
      window.onscroll = function() {
        scrollFunction();
      };

      function scrollFunction() {
        if (
          document.body.scrollTop > 200 ||
          document.documentElement.scrollTop > 200
        ) {
          document.getElementById("myBtn").style.display = "block";
        } else {
          document.getElementById("myBtn").style.display = "none";
        }
      }

      // When the user clicks on the button, scroll to the top of the document
      function topFunction() {
        document.body.scrollTop = 0;
        document.documentElement.scrollTop = 0;
      }
    </script>

    <div class="progress-container">
      <div class="progress-bar" id="myBar"></div>
    </div>

    <script>
      // When the user scrolls the page, execute myFunction
      document.onscroll = function() {
        myProgress();
      };

      function myProgress() {
        var winScroll =
          document.body.scrollTop || document.documentElement.scrollTop;
        var height =
          document.documentElement.scrollHeight -
          document.documentElement.clientHeight;
        var scrolled = (winScroll / height) * 100;
        document.getElementById("myBar").style.width = scrolled + "%";
      }
    </script>

    <!--
      ------------------------------------------------------TOP MENU---------------------------------------------------------------
    -->

    <div id="topnav">
      <nav>
        <ul id="menu">
          <li><a href="#">Home</a></li>

          <li style="margin-bottom: 0;">
            <a href="https://2019.igem.org/Team:Aalto-Helsinki/Description"
              >Project</a
            >

            <ul class="submenu" style="margin: 0 0 0 0;">
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Description"
                  >Description</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Design"
                  >Design</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Demonstrate"
                  >Demonstrate</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Notebook"
                  >Notebook</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Contribution"
                  >Contribution</a
                >
              </li>
            </ul>
          </li>

          <li style="margin-bottom: 0;">
            <a href="https://2019.igem.org/Team:Aalto-Helsinki/Lab">Lab</a>
            <ul class="submenu" style="margin: 0 0 0 0;">
              <li
                style="font-size: 20px; padding: 5px 10px 0px 10px; margin-bottom: 0;"
              >
                Wet Lab
                <ul class="submenu" style="margin: 0 0 0 0;">
                  <li style="margin-bottom: 0;">
                    <a href="https://2019.igem.org/Team:Aalto-Helsinki/Safety"
                      >Safety</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Experiments"
                      >Experiments</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a href="https://2019.igem.org/Team:Aalto-Helsinki/Results"
                      >Results</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a href="https://2019.igem.org/Team:Aalto-Helsinki/Lab_Book"
                      >Lab book</a
                    >
                  </li>
                </ul>
              </li>
              <li
                style="font-size: 20px; padding: 5px 10px 0px 10px; margin-bottom: 0;"
              >
                Dry Lab
                <ul class="submenu" style="margin: 0 0 0 0;">
                  <li style="margin-bottom: 0;">
                    <a href="https://2019.igem.org/Team:Aalto-Helsinki/Model"
                      >Model overview</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Model/Growth_rate"
                      >Growth rate</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Model/Simulations"
                      >Simulations</a
                    >
                  </li>
                </ul>
              </li>
            </ul>
          </li>

          <li style="margin-bottom: 0;">
            <a href="https://2019.igem.org/Team:Aalto-Helsinki/Parts">Parts</a>
            <ul class="submenu" style="margin: 0 0 0 0;">
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Basic_Part"
                  >Basic Parts</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a
                  href="https://2019.igem.org/Team:Aalto-Helsinki/Composite_Part"
                  >Composite Parts</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Improve"
                  >Improved parts</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a
                  href="https://2019.igem.org/Team:Aalto-Helsinki/Part_Collection"
                  >Collection</a
                >
              </li>
            </ul>
          </li>

          <li style="margin-bottom: 0;">
            <a href="https://2019.igem.org/Team:Aalto-Helsinki/Human_Practices"
              >Human Practices</a
            >
            <ul class="submenu" style="margin: 0 0 0 0;">
              <li style="margin-bottom: 0;">
                <a
                  href="https://2019.igem.org/Team:Aalto-Helsinki/Public_Engagement"
                  >Education & Public Engagement</a
                >
                <ul class="submenu" style="margin: 0 0 0 0;">
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Public_Engagement/Events"
                      >Events</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Public_Engagement/Podcast"
                      >Podcast</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Collaborations"
                      >Collaborations</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Public_Engagement/Conferences"
                      >Conferences</a
                    >
                  </li>
                </ul>
              </li>
              <li style="margin-bottom: 0;">
                <a
                  href="https://2019.igem.org/Team:Aalto-Helsinki/Human_Practices"
                  >Integrated Human Practices</a
                >
                <ul class="submenu" style="margin: 0 0 0 0;">
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Human_Practices/Design_Thinking"
                      >Design Thinking</a
                    >
                  </li>
                  <li style="margin-bottom: 0;">
                    <a
                      href="https://2019.igem.org/Team:Aalto-Helsinki/Entrepreneurship"
                      >Entrepreneurship</a
                    >
                  </li>
                </ul>
              </li>
            </ul>
          </li>

          <li style="margin-bottom: 0;">
            <a href="https://2019.igem.org/Team:Aalto-Helsinki/Team">Team</a>
            <ul class="submenu" style="margin: 0 0 0 0;">
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Contribution"
                  >Contribution</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Attributions"
                  >Attributions</a
                >
              </li>
              <li style="margin-bottom: 0;">
                <a href="https://2019.igem.org/Team:Aalto-Helsinki/Sponsors"
                  >Sponsors</a
                >
              </li>
            </ul>
          </li>

          <li id="mainmenu">
            <a href="https://2019.igem.org/Team:Aalto-Helsinki/Awards"
              >Awards</a
            >
          </li>
        </ul>
      </nav>
    </div>

    <!-- CONTENT -->
    <div class="hometext">
      <div class="pdsection0">
        <h1
          style="text-align: left; padding-top: 3%; padding-bottom: 2%; padding-left: 5%;"
        >
          PROJECT DESCRIPTION
        </h1>
      </div>
      <div class="pdsection1">
        <h1
          style="text-align: right; padding-right: 10%; color: white; padding-left: 5%"
        >
          INTRODUCTION
        </h1>
        <p class="maintext" id="pd-introduction">
          Recombinant proteins are widely used in biomedical research and as
          biopharmaceutical compounds. Several methods for protein production
          have been established during the past decades providing aid for
          millions of people. However, even with today’s technologies, improved
          efficacy is urgent as the demand for recombinant proteins is only
          increasing. It has been estimated that within the next 10 years half
          of all new developed medicines will be biopharmaceuticals, including
          recombinant proteins (Jozala et al., 2016).
        </p>
      </div>
      <div class="pdsection2">
        <p
          class="maintext"
          id="pd-introduction"
          style="text-align: center; padding-top: 4%;"
        >
          Biotechnology solutions have strongly focused on using production
          platforms based on the bacterium Escherichia coli, which is used in
          the production of as many as half of approved recombinant protein
          therapeutics. Other platforms include many species of yeast, as well
          as some mammalian cell lines. However, no platform is optimal in all
          therapeutic protein production, which is why introducing new platforms
          has the potential to diversify and increase the performance of
          recombinant protein production (Merlin et al., 2014).
        </p>
      </div>
      <div class="pdsection3">
        <p class="maintext" id="pd-introduction">
          Vibrio natriegens is challenging Escherichia coli as the organism of
          choice for research and biotechnology applications. With a generation
          time of under 10 minutes, this Gram-negative marine bacterium is the
          fastest growing organism known to date (Weinstock et al., 2016).
          Combined with the ability to effectively produce large amounts of
          soluble protein and secrete them into the growth medium, these traits
          make Vibrio natriegens an ideal chassis organism.
        </p>
      </div>
      <div class="pdsection4">
        <h1 style="text-align: center; padding-top: 3%; padding-bottom: 2%;">
          Aalto-Helsinki would like to introduce you to
        </h1>
        <img
          src="finalpics/home/blueblack.png"
          style="width: 25%; padding-left: 38%;"
        />
        <h1
          style="font-size: 20px; text-align: center; padding-top: 3%; padding-bottom: 2%;"
        >
          Vibrio natriegens with Xtreme Protein Expression and Secretion System
          Optimization
        </h1>
      </div>
      <div class="pdsection5">
        <p class="maintext" id="pd-introduction">
          Our iGEM project introduces VibXPresso - Vibrio natriegens with Xtreme
          PRotein Expression and Secretion Optimization. We harness the
          Gram-negative bacterium's generation time of under 10 minutes (Lee et
          al., 2016) to rapidly produce large amounts of protein for efficient
          downstream processing. This can be achieved via the twin-arginine
          translocation (Tat) pathway, which transports proteins into the
          bacterium's periplasm (Browning et al., 2017). We researched the
          possibility of utilizing environmental modifications to further
          secrete proteins from the periplasm into the medium to further ease
          the protein purification.
        </p>
      </div>

      <div class="pdgrid">
        <div class="pditem1">
          <h1
            style="padding-top: 3%; padding-bottom: 2%; font-size: 22px; padding-left: 5%;"
          >
            XTREME PROTEIN EXPRESSION
          </h1>
          <p
            class="maintext"
            id="pd-introduction"
            style="text-align: justify; padding-right: 15%;"
          >
            Vibrio natriegens has many desirable characteristics to serve as an
            ideal bacterial chassis for metabolic engineering and recombinant
            protein production, including features such as fast growth rate, the
            ability to grow on minimal medium, translocation pathways for
            protein secretion, and a variety of tools for engineering the genome
            and gene expression (Lee et al., 2016; Team Marburg iGEM, 2018;
            Calero & Nikel, 2019). Shared characteristics with E. coli also
            enable the application of several already developed E. coli
            techniques and protocols on V. natriegens.
          </p>
        </div>
        <div class="pditem1">
          <p class="maintext">
            In order to increase the protein production and engineering
            capabilities of V. natriegens, we planned several chromosomal
            modifications including ones already performed, like the deletion of
            extracellular nuclease gene dns to improve plasmid transformation
            efficiency (Weinstock et al., 2014; Dalia et al., 2017; Team Marburg
            iGEM, 2018), and some that haven’t been done before to our
            knowledge, like the knockout of protease genes to decrease
            intracellular and periplasmic protein degradation rate. In theory,
            introducing chromosomal modifications in V. natriegens is
            straightforward due to the presence of natural competence inducing
            tfoX gene (Dalia et al., 2017). Before running out of time, we
            attempted to produce the first planned mutation, dns deletion (see
            Results).
          </p>
        </div>
        <div class="pditem2">
          <img
            src="finalpics/description/expression.png"
            style="width: 100%;"
          />
        </div>
        <div class="pditem3">
          <img
            src="finalpics/description/secretion.png"
            style="width: 100%; padding-left: 10%;"
          />
        </div>
        <div class="pditem4">
          <h1
            style="padding-top: 3%; padding-bottom: 2%; font-size: 22px; text-align: right; padding-right: 5%;"
          >
            XTREME PROTEIN SECRETION
          </h1>
          <p class="maintext">
            V. natriegens’ ability to secrete proteins into periplasm offers
            several advantages. First, many biopharmaceuticals contain disulfide
            bridges, which can only form in gram-negative bacterium’s periplasm
            (5). Second, proteins in periplasmic space are easier to purify
            without contaminant cell debris or DNA, in comparison to cytoplasmic
            proteins. Periplasmic space also offers the possibility to secrete
            proteins into the medium through leaky outer membrane, which enables
            even easier access to purify the protein product, and lowers the
            costs of downstream processing.
          </p>

          <p class="maintext">
            To achieve this, we are taking advantage of the twin-arginine
            translocation pathway (Tat) that transports fully folded proteins
            from gram-negative bacterium’s cytoplasm to the periplasmic space.
            Proteins transported in vivo via the Tat pathway include membrane
            proteins, redox enzymes, and multimeric proteins. In V. natriegens
            the Tat pathway consists of three subunit proteins (TatA, TatB, and
            TatC – homologous to E. coli (7)), and can transport substrates up
            to 150 kDa in size (9).
          </p>

          <p class="maintext">
            In order to utilise the Tat system in our project, we identified
            several secretion peptides for V. natriegens. Next, to demonstrate
            the potential of V. natriegens as a secretive cell factory, we
            expressed the human growth hormone (hGH) with a Tat pathway signal
            peptide attached to it. hGH is used to treat growth deficiencies and
            genetic disorders, and it has already been proven to be secreted
            through the Tat pathway in E. coli with appropriate signal peptide
            (5). Our system over-expresses the tatAB and tatC operon of V.
            natriegens together with plasmid based hGH in a similar fashion to
            E. coli “TatExpress” strain described by Browning et al (5). This
            setup allows us to demonstrate the versatility and potential of V.
            natriegens in recombinant protein production.
          </p>
        </div>
      </div>

      <div class="pdsection6">
        <h1 style="padding-left: 10%; padding-right: 5%; color: white;">
          INVESTIGATION OF IMPLEMENTING OUR SOLUTION
        </h1>
        <p class="maintext" id="pd-introduction" style="text-align: justify;">
          As many as one out of four diabetic patients cannot afford their
          medication (Herkert et al., 2019). The high prices remain an issue for
          also patients depending on other biopharmaceuticals. As part of our
          project design, we wanted to explore how VibXPresso could eventually
          be integrated into the pharmaceutical manufacturing processes while
          assuring affordable medication. We utilized design thinking methods
          and interviewed different stakeholders to guarantee an integration
          between our project’s scientific as well as human practices designs.
          To address the inequality in accessing therapeutic protein treatment,
          we created a business model for how VibXPresso could be utilized to
          solve the identified pain points: unaffordability of therapeutic
          protein products and the growing demand for biopharmaceutical
          development and production tools. The final outcome of our project was
          strongly influenced by the input from stakeholders. Thus ensuring that
          there is a real need for our solution
        </p>
      </div>

      <div class="pdsection7">
        <h1
          style="padding-left: 5%; padding-right: 5%; color: rgb(0, 0, 0); font-size: 15px;"
        >
          REFERENCES
        </h1>
        <p
          class="maintext"
          id="pd-introduction"
          style="font-size: 12px; padding-bottom: 2%;"
        >
          1. Jozala, A. F., Geraldes, D. C., Tundisi, L. L., Feitosa, V. D. A.,
          Breyer, C. A., Cardoso, S. L., ... & Oliveira, M. A. D. (2016).
          Biopharmaceuticals from microorganisms: from production to
          purification. brazilian journal of microbiology, 47, 51-63.<br />
          2. Merlin, M., Gecchele, E., Capaldi, S., Pezzotti, M., & Avesani, L.
          (2014). Comparative evaluation of recombinant protein production in
          different biofactories: the green perspective. BioMed research
          international, 2014, 136419. doi:10.1155/2014/136419<br />
          3. Weinstock, M. T., Hesek, E. D., Wilson, C. M., & Gibson, D. G.
          (2016). Vibrio natriegens as a fast-growing host for molecular
          biology. Nature Methods, 13(10), 849. <br />
          4. Lee, H. H., Ostrov, N., Wong, B. G., Gold, M. A., Khalil, A. S., &
          Church, G. M. (2016). Vibrio natriegens, a new genomic powerhouse.
          bioRxiv, 058487. <br />
          5. Browning, D. F., Richards, K. L., Peswani, A. R., Roobol, J.,
          Busby, S. J. W., & Robinson, C. (2017). Escherichia coli "TatExpress"
          strains super-secrete human growth hormone into the bacterial
          periplasm by the Tat pathway. Biotechnol Bioeng, 114(12), 2828-2836.
          <br />
          6. Team Marburg iGEM 2018. (2018). Description. Retrieved from
          http://2018.igem.org/Team:Marburg/Description <br />
          7. Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes
          and Genomes. Nucleic Acids Research, 28(1), 27-30.<br />
          8. Sharma, S. S., Blattner, F. R., & Harcum, S. W. (2006). Recombinant
          protein production in an Escherichia coli reduced genome strain.
          Metabolic engineering, 9(2), 133–141. <br />
          9. Burdette, L. A., Leach, S. A., Wong, H. T., & Tullman-Ercek, D.
          (2018). Developing Gram-negative bacteria for the secretion of
          heterologous proteins. Microbial cell factories, 17(1), 196. <br />
          10. Study finds 1 in 4 patients can’t afford insulin. (2019).
          Retrieved 18 July 2019, from
          https://www.pharmacist.com/article/study-finds-1-4-patients-cant-afford-insulin<br />
          11. Calero, P., & Nikel, P. I. (2019). Chasing bacterial chassis for
          metabolic engineering: a perspective review from classical to
          non-traditional microorganisms. Microb Biotechnol, 12(1), 98-124.
          <br />
        </p>
      </div>
    </div>

    <!--
      -------------------------------button grid----------------------------------------
    -->

    <div class="homegrid">
      <div
        class="homegrid-item"
        id="homegrid-text"
        style="background-image: url(bgpics/022.jpg); background-size: cover;"
      >
        <a href="https://2019.igem.org/Team:Aalto-Helsinki/Description"
          >PROJECT</a
        >
      </div>
      <div
        class="homegrid-item"
        id="homegrid-text"
        style="background-image: url(bgpics/011.jpg); background-size: cover;"
      >
        <a href="https://2019.igem.org/Team:Aalto-Helsinki/Lab">LAB</a>
      </div>
      <div
        class="homegrid-item"
        id="homegrid-text"
        style="background-image: url(bgpics/033.jpg); background-size: cover;"
      >
        <a href="https://2019.igem.org/Team:Aalto-Helsinki/Human_Practices"
          >HUMAN<br />OUTREACH</a
        >
      </div>
    </div>

    <!--
      ------------------------------------------------------PARTNERS---------------------------------------------------------------
    -->

    <div id="partners">
      <div class="row">
        <div class="column1">
          <img class="photo" src="logos/dark/Aalto_BIZ_black.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/Aalto_CHE_EN_black.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/Aalto_ELEC_EN_black.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/Aalto_ENG_EN_black.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/Aalto_SCI_EN_black.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/df_black.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/Helsinki.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/supported-by-hilife.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/Kemianteollisuus_black.png" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/LOIMU.jpg" />
        </div>
        <div class="column1">
          <img class="photo" src="logos/dark/ThermoFisher_black.jpg" />
        </div>
      </div>
    </div>

    <!--
      ------------------------------------------------------FOOTER---------------------------------------------------------------
    -->
    <div class="footer">
      <a class="icon" id="fb" href="https://www.facebook.com/AaltoHelsinki"
        ><i class="fab fa-facebook-square"></i
      ></a>
      <a class="icon" id="twi" href="https://twitter.com/AaltoHelsinki"
        ><i class="fab fa-twitter"></i
      ></a>
      <a class="icon" id="ig" href="https://instagram.com/aaltohelsinki_igem"
        ><i class="fab fa-instagram"></i
      ></a>
      <a class="icon" id="blog" href="http://blog.aaltohelsinki.com"
        ><i class="fab fa-tumblr-square"></i></a
      ><br />
      Kemistintie 1, Espoo, Finland<br />
      team@aaltohelsinki.com
    </div>
  </body>
</html>
